Warhound, a startup backed by Colossal Biosciences, has emerged from stealth with $200 million in funding to develop genetically engineered working dogs equipped with advanced technology from defense company Anduril.
The company aims to produce dogs with improved health, physical capabilities, and specialized skills for military operations, law enforcement, and emergency response. The project combines genetic engineering with protective equipment and digital systems designed to help handlers monitor and coordinate their dogs in the field.
Warhound has been valued at $1.2 billion following the funding round, which includes investments from Sequoia, 8VC, and In-Q-Tel, a venture firm associated with the US intelligence community.
What Happened?
Warhound was founded around an idea developed by Ben Lamm, co-founder and CEO of Colossal Biosciences, and Palmer Luckey, founder of Anduril Industries. The venture aims to address challenges in the supply and suitability of working dogs used by military and law enforcement agencies.
Working dogs play an important role in detecting explosives, searching buildings and difficult terrain, and supporting operations where sending a human or relying entirely on a machine may be challenging.
However, selecting dogs with the right physical characteristics and health profiles can be difficult. According to Warhound’s launch announcement, more than 80% of the US military’s working dogs come from Europe, and fewer than half of the dogs considered for service are suitable for the role.
Warhound wants to develop dogs specifically suited to demanding operational environments rather than relying entirely on conventional breeding.
What Has Warhound Announced?
The startup plans to combine genetic engineering, cloning, and technology-assisted equipment to develop a new generation of working dogs.
Colossal Biosciences will contribute its genetic engineering capabilities, while Anduril will provide hardware and software intended to improve communication between dogs and their handlers.
The project is still in development. The company has not yet deployed its proposed genetically engineered dogs in operational service.
Key Details of the Warhound Project
1. Genetic Engineering for Specialized Tasks
Warhound plans to study and modify the genetics of working dog breeds, particularly the Belgian Malinois and German Shepherd. These breeds are already widely associated with demanding working roles.
According to Ben Lamm, the research will explore characteristics such as health, longevity, speed, agility, and the ability to detect scents. Improving these traits could help dogs perform specialized tasks, including explosive detection and search operations.
The company has collected cell lines from these breeds for a biobank. It intends to use genetic engineering to modify selected traits, although the final capabilities and safety of the resulting dogs remain to be demonstrated.
2. Cloning and Development Timeline
Warhound plans to work with ViaGen, a cloning company owned by Colossal Biosciences, to produce its first dogs.
Lamm told TechCrunch that the initial group was approaching the cloning and incubation stage, with births expected in early 2027. The company hopes the dogs could begin service within approximately two years of the announcement.
These are company targets rather than confirmed milestones, and the timeline may change as development progresses.
3. Anduril’s Technology for Dogs and Handlers
Anduril is expected to contribute protective equipment and digital technology to support working dogs.
Potential equipment includes protective vests and goggles, as well as sensors that could send information to human handlers. Such systems could help handlers better understand the dog’s surroundings and coordinate activities during dangerous missions.
The concept is to improve operational safety through equipment and software in addition to any changes made through genetic engineering.
4. A $200 Million Funding Round
Warhound has secured $200 million from investors including Sequoia, 8VC, and In-Q-Tel. The funding round values the company at $1.2 billion.
The investment will support the development of the company’s proposed technology and its plans to produce specialized working dogs. The announcement also highlights investor interest in technologies combining biotechnology with defense and security applications.
Why Does This Matter?
Reducing Dependence on Imported Working Dogs
Warhound argues that the United States needs a more reliable supply of dogs suitable for military and law enforcement duties. If its approach succeeds, the company could offer another way to develop dogs for specific operational requirements.
However, the actual effect on supply and availability will depend on the program’s eventual results and ability to produce dogs at scale.
Combining Biotechnology With Defense Technology
The project brings together two different areas of technological development: genetic engineering and advanced defense equipment.
Genetic engineering could potentially help researchers investigate inherited health and performance traits, while sensors and protective equipment could support handlers during field operations.
Whether combining these technologies produces meaningful operational advantages will require testing and evidence.
Raising Questions About Animal Welfare
Genetically engineering animals for demanding military work also raises questions about animal welfare, inherited health risks, and the long-term effects of genetic modifications.
Warhound says it is working under the guidance of the American Humane Society to help certify its training program. The company also hopes retired dogs will be placed through the Society’s Military Working Dog Reunification Program or another suitable program.
These plans will be important as the project develops, but they do not yet establish the long-term safety or welfare outcomes of genetically engineered working dogs.
Who Could Be Affected?
Military and defense agencies: The US Department of Defense and military service organizations could become potential customers if the dogs meet operational and procurement requirements.
Police and emergency response teams: Law enforcement and first responders may be interested in specialized dogs for searches, detection, and other dangerous tasks.
Biotechnology and defense companies: The project could attract attention from businesses exploring the use of genetic engineering, cloning, sensors, and software in security-related applications.
Animal welfare organizations: Groups concerned with animal health and ethical breeding may scrutinize the methods used to develop, train, deploy, and retire these dogs.
What Happens Next?
Warhound’s immediate priorities include producing its first dogs, continuing genetic engineering research, and developing the equipment intended to support handlers.
The company also needs to establish how its dogs will be trained, evaluated, priced, and supplied to potential customers. Government procurement requirements and applicable regulatory considerations will be important as the project moves forward.
The planned births in early 2027 and the target of beginning service within roughly two years will be key milestones to watch. The company will ultimately need to demonstrate that its approach can produce healthy dogs capable of performing their intended duties.
Conclusion
Warhound’s $200 million funding round marks an ambitious attempt to combine biotechnology with military working dog programs. With Colossal Biosciences contributing genetic engineering and cloning expertise and Anduril developing supporting equipment and software, the startup aims to create dogs suited to specialized and potentially dangerous missions.
For now, the project remains at the development stage. Its long-term significance will depend on whether Warhound can demonstrate reliable performance, protect animal welfare, and meet the practical requirements of military and law enforcement customers.